Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pulmonary Sarcoidosis
Chronic Lung Disease
Phenylketonuria
Maple Syrup Urine Disease
Rare Diseases
Pharmaceutical
Metabolic Disorders
Urea Cycle Disorders
Clinical Trials
Genetic Medicine
Acute Respiratory Distress Syndrome
Acute Lung Disease
MSUD
Lung Fibrosis
UCD
PKU
EB
Acute Lung Injury
ARDS
Rare Disease
Epidermolysis Bullosa
Date founded
2013
Funding rounds raised
Total raised
$2.8M
from 1 investors over 1 rounds
R
RELIEF THERAPEUTICS Holding AG raised $2.8M on May 24, 2016
Investors: GEM Management Limited